Clal Biotechnology Industries Ltd. (TLV: CBI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
34.80
-0.80 (-2.25%)
Dec 19, 2024, 5:24 PM IDT

TLV: CBI Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
546298185319211
Upgrade
Market Cap Growth
-36.70%-36.78%-46.87%-41.79%51.02%-51.47%
Upgrade
Enterprise Value
90109144336496419
Upgrade
Last Close Price
0.340.400.631.181.751.16
Upgrade
PE Ratio
----2.92-
Upgrade
PS Ratio
1597.87598.73266.21827.641546.131.86
Upgrade
PB Ratio
0.910.510.680.550.620.42
Upgrade
P/TBV Ratio
0.850.630.78-4.88-
Upgrade
P/FCF Ratio
-----8.72
Upgrade
P/OCF Ratio
-----7.80
Upgrade
EV/Sales Ratio
2986.961046.55389.641498.602405.763.70
Upgrade
EV/EBITDA Ratio
--31.3534.0237.4748.87
Upgrade
EV/FCF Ratio
-----17.33
Upgrade
Debt / Equity Ratio
0.280.290.250.160.100.13
Upgrade
Debt / EBITDA Ratio
--7.155.453.847.30
Upgrade
Debt / FCF Ratio
-----2.59
Upgrade
Asset Turnover
0.000.000.000.000.000.14
Upgrade
Inventory Turnover
-----9.75
Upgrade
Quick Ratio
2.182.014.651.706.953.14
Upgrade
Current Ratio
2.182.215.712.187.463.35
Upgrade
Return on Equity (ROE)
-60.69%-21.10%-16.98%-15.63%25.13%-47.78%
Upgrade
Return on Assets (ROA)
-3.36%-3.73%-2.49%-1.49%-1.08%-0.95%
Upgrade
Return on Capital (ROIC)
-3.42%-3.76%-2.72%-1.65%-1.18%-1.05%
Upgrade
Earnings Yield
-146.17%-49.87%-62.68%-48.32%34.23%-73.07%
Upgrade
FCF Yield
-15.75%-13.68%-61.23%-23.15%-11.43%11.47%
Upgrade
Dividend Yield
0.00%---12.54%-
Upgrade
Buyback Yield / Dilution
-24.92%-1.01%1.74%-0.01%-1.70%
Upgrade
Total Shareholder Return
-24.92%-1.01%1.74%12.53%-1.70%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.